Latest Vision 2030 News

Page 3 of 3
Imricor Medical Systems reports strong Q4 CY24 progress with successful FDA review, CE Mark submissions, and an 840% jump in consumables revenue, positioning the company for expanded global market penetration.
Ada Torres
Ada Torres
23 Jan 2025